Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Crpc

PSA Drop Seen with New Prostate Cancer Drug

Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator, data from a preliminary clinical study showed.

During 12 weeks of treatment with galeterone, prostate-specific antigen (PSA) declined by at least 30% in 24 of 49 patients, 11 of whom had declines… PSA Drop Seen with New Prostate Cancer Drug   



Antifungal May Help in Prostate Cancer

Men with castration-resistant prostate cancer (CRPC) that was not mediated by androgen suppression experienced better outcomes when treated with an antifungal agent, according to a small clinical study reported here.

Men treated with the maximum recommended dose of itraconazole had a median progression-free survival (PFS) of 36 weeks, and 61% of the patients were… Antifungal May Help in Prostate Cancer   



Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded

A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednisone, is effective in treating mildly symptomatic or asymptomatic patients who are suffering from metastatic castration-resistant prostate cancer (CRPC) and have not gone through chemotherapy. … Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded   



For advanced prostate cancer, new drug slows disease

A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.

The study is the first randomized… For advanced prostate cancer, new drug slows disease   



urologist1 - bladder control4 - arteriovenous blood1 - diagnostic test2 - recurrent hematuria1 - personalized cancer medicine1 - metastasize1 - kidney tumors1 - robotic-assisted operations1 - rokitansky syndrome1 - seizure1 - canadian medical association journal2 - prostate mri guidelines1 - urinary calculi3 - renal function2 - bone pain1 - journal of the american medical association1 - demeclocycline1 - uterine2 - renal tomography4 - urine7 - lower urinary tract8 - arsenic1 - thiazide diuretic1 - conners parent rating scale-revised1 - distal tubule1 - dehydration1 - bristol stool scale1 - mri scan1 - hormone replacement1 -